Navigation Links
In Age of Patent Expiration, Planning Groups for New Pharma Products Growing in Importance
Date:3/9/2013

CHAPEL HILL, N.C., March 9, 2013 /PRNewswire/ -- New product launch groups in the bio-pharmaceutical industry are often faced with dueling pressures of efficiently developing new products with minimum risk and maximum value. In addition, new product commercialization efforts have taken on increased importance in recent years. With the expiration of patents becoming a looming concern across the biopharma industry, individual companies must now, more than ever, find a way to effectively develop new products in a timely manner.

To address various issues related to the critical elements of the new product planning (NPP) function in bio-pharma companies, Best Practices, LLC completed a benchmarking study. The report, "Pharmaceutical New Product Planning: Structure and Activities to Drive Growth and Profitability," addresses the critical roles and structure of NPP groups.

The report provides professionals with actionable insights into critical aspects of the NPP function, such as coordinating regional and global efforts and carrying out dozens of activities that generate commercial insights. Other key study topics include:

  • Benchmarks of NPP group structures, roles, responsibilities, and attributes
  • Assessments of the levers of impact and  effectiveness
  • Definitions of interactions and optimal working relationships between Regional and Global NPP groups
  • Discoveries surrounding the full set of activities NPP groups perform, their timing, intended outcomes, and value for the organization
  • Insights into the future of the NPP function

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 27 New Product Planning leaders at 25 pharma companies across the globe contributed data. In-depth interviews were conducted with leaders from over a dozen of the participating companies.

In addition, Best Practices has found that the role of the NPP function has expanded and has continued to change in recent years. In order to expand upon previous research and benchmarks, Best Practices recently launched a new study that focuses on the importance of the NPP function in the biopharmaceutical industry.

To participate in the online survey, follow this link: http://www.surveygizmo.com/s3/1168398/Pharmaceutical-New-Product-Planning-Excellence-Structure-Activities-that-Drive-Profitability-Growth.

To download a complimentary excerpt from the initial report, go to: http://www3.best-in-class.com/rr992.htm

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or visit our website at bestpractices@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

 

 

 


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. OrbusNeich File Patent Infringement Lawsuit Against Boston Scientific in Ireland
2. Amedica Expands Patent Portfolio with Proprietary Silicon Nitride Total Disc Implant to Treat Neck and Back Pain
3. BioElectronics Announces Publication of Patent Application
4. OrbusNeich Files Patent Infringement Actions Against Boston Scientific in Germany and the Netherlands
5. Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
6. Terumo Medical Corporation Files Patent Infringement Lawsuit Against Vascular Solutions And Lepu Medical Technology Company
7. High Profile HealthCare Companies: Leading Pharma Company Secures New Patents
8. Rosetta Genomics Receives Two Key U.S. Patent Allowances
9. Immunotech Laboratories Receives $2M Funding Approval To Begin European Clinical Trials Testing For Companys Patented "IPF" HIV-AIDS Medicines
10. Japan Biosimilars - ¥200b Worth of Biologic Products Going Off Patent by 2015
11. OrbusNeich Announces Favorable Ruling From the European Patent Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... -- Mettler-Toledo International Inc. (NYSE: MTD ) today ... the highlights: , Sales in local currency ... year.  Reported sales decreased 3% as currency reduced sales ... earnings per diluted share as reported (EPS) were $4.44, ... EPS was $4.65, an increase of 10% over the ...
(Date:2/4/2016)... -- In response to the opioid abuse epidemic, today Dr. ... Products and Tobacco, along with other FDA leaders, called for ... opioid medications. The plan will focus on policies aimed at ... to effective relief. --> ... risk-benefit paradigm for opioids and ensure that the agency considers ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... VeloReality President ... next generation LYNX VR Indoor Trainer with multi-rider capability to an enthusiastic audience ... not only reduce the weight of the unit, they also enhance the rider's ...
(Date:2/5/2016)... ... February 05, 2016 , ... Francisco Canales, MD and Heather ... Napa Valley office. The technique utilizes the body’s own healing abilities to quickly ... Furnas, are part of only a select few cosmetic surgeons bringing this procedure ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps , official ... NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally situated in ... from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We are ...
(Date:2/5/2016)... ... ... Boar’s Head Brand®, one of the nation’s leading providers of premium delicatessen foods, ... out of your party preparation – follow these easy, yet delicious recipes with the ... , “The key to hosting a successful game-day party is creating a flavorful menu ...
(Date:2/5/2016)... Francisco, CA (PRWEB) , ... February 05, 2016 ... ... and founder of CitiDent, announces that it is now welcoming orthodontist, ... Dr. Cheng, CitiDent offers a complete range of oral health care, including general ...
Breaking Medicine News(10 mins):